| Sep 19 |
Elanco Announces FDA Approval and Launch of Zenrelia™ (ilunocitinib tablets), Offering An Effective, Safe Solution in Canine Dermatology
|
| Sep 19 |
Elanco rises on FDA approval for Zenrelia
|
| Sep 19 |
US FDA approves Elanco's skin disease treatment for dogs
|
| Sep 19 |
Elanco downgraded to Equal-Weight at Morgan Stanley on near-term competition concerns
|
| Sep 13 |
Elanco sees EBITDA impact as contract manufacturer faces insolvency
|
| Sep 13 |
Elanco Provides Update on Contract Manufacturing Partner
|
| Sep 6 |
Bullish Elanco Animal Health Insiders Loaded Up On US$2.23m Of Stock
|
| Aug 28 |
Elanco to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
|
| Aug 20 |
Elanco Announces Credelio Quattro Moves to Final FDA Administrative Review
|
| Aug 16 |
Elanco Animal Health: Positioned For Success
|
